Advance Care Planning in Palliative Care (ANTICIPALL)

What Are the Views of Palliative Care Patients Regarding the Use of Anticipatory Prescribing ?

The question of the end of life is a major public health issue. In the field of palliative care, the notion of anticipation is central for people with a serious and progressive illness. Indeed, an important consideration for general practitioners is the need to anticipate the disease's evolution and the uncomfortable symptoms (physical or psychological) the patient is likely to experience. This approach aims to relieve the patient without delay and thus improve comfort to ensure an acceptable quality of life for patients and their families. Even if the usefulness of anticipatory prescribing seems obvious, their use is not generalized to all palliative care patients. Caregivers are confronted with obstacles to the implementation of these prescriptions, particularly with regard to the relationship with the patient. It can then be assumed that patients' experiences and perceptions may influence symptom management and the use of anticipatory prescriptions. It seems essential to explore this subject. For this purpose, the investigator will carry out a qualitative study based on individual semi-structured interviews with palliative care patients.

Study Overview

• Status: Recruiting
• Conditions: Palliative Care
• Intervention / Treatment: Behavioral: Individual semi-structured interviews

• Study Type: Observational
• Enrollment (Estimated): 10

Contacts and Locations

• Study Contact: Name: Manon JULLIAN; Phone Number: +33 4 78 07 30 91; Email: manonjullian@hotmail.fr
• Study Contact Backup: Name: Julien TRAUTMANN, MD; Phone Number: +33 4 78 07 31 38; Email: jtrautmann@ch-givors.fr

Study Locations

• France
  • Givors, France, 69700
    • Recruiting
    • Givors Hospital Center - Multidisciplinary medicine and palliative care department
    • Contact: Julien TRAUTMANN, MD; Phone Number: +33 4 78 07 31 38; Email: jtrautmann@ch-givors.fr
    • Contact: Manon JULLIAN; Phone Number: +33 4 78 07 30 91; Email: mjullian@ch-givors.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

The study population concerns patients in palliative situation, either hospitalized in palliative care unit or followed at home by the Mobile Palliative Care Team. The number of subjects required is estimated at a minimum of 15 participants (depend on data saturation)

Description

Inclusion Criteria:

• Persons of all genders
• Persons 18 years of age and older
• In a palliative care situation of any serious illness
• Persons hospitalized in palliative care unit at the Givors hospital or followed at home by the Mobile Palliative Care Team
• Patients who have received full information about the study and signed a written consent.

Exclusion Criteria:

• Persons under legal protection
• Persons unable to express their consent, making it impossible to conduct interviews: dysarthria, cognitive disorders, mental confusion, altered state of consciousness
• Pregnant or breastfeeding persons

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Palliative care patients; Palliative care patients; Suffering from a serious and progressive illness (whatever it is); Hospitalized in a palliative care unit or followed at home by the hospital's mobile palliative care team

Behavioral: Individual semi-structured interviews; After information and written consent, the investigator will interview the participants through a semi-structured individual interview (conducted by an interview guide). The interview is expected to last 45 minutes (variable depending on the subject). It will be recorded by dictaphone, respecting the anonymity of the participant throughout the interview. The subject's participation will end after the interview.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The primary outcome is patient views on the use of anticipatory prescribing.	The interview consists in exploring the participants' experiences (feelings, representations), expectations and difficulties concerning the use of anticipatory prescribing. Interviews will be audio recorded. The verbatim will be transcribed for qualitative analysis by inductive thematic type, in order to bring out the main ideas and hypotheses.	The outcome will be collected at Day 1-End of study visit

Collaborators and Investigators

• Sponsor: Hospices Civils de Lyon
• Investigators: Principal Investigator: Manon JULLIAN, Multidisciplinary medicine and palliative care department

Study record dates

Study Major Dates

• Study Start (Actual): March 10, 2023
• Primary Completion (Estimated): December 10, 2023
• Study Completion (Estimated): December 10, 2023

Study Registration Dates

• First Submitted: December 12, 2022
• First Submitted That Met QC Criteria: December 20, 2022
• First Posted (Actual): December 23, 2022

Study Record Updates

• Last Update Posted (Actual): August 8, 2023
• Last Update Submitted That Met QC Criteria: August 7, 2023
• Last Verified: August 1, 2023

More Information

Terms related to this study

• Keywords: Palliative care; Advance care planning; Patient experiences; End of life; Anticipatory prescribing
• Other Study ID Numbers: 69HCL22_0747; ID-RCB (Other Identifier: 2026-A00289-42)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No